Protective effects of dietary PUFA against chronic disease: evidence from epidemiological studies and intervention trials. Issue 1 (5th December 2013)

• Record Type: Journal Article
• Authors: Sanders, Thomas A. B.
• Is Part Of: Proceedings of the Nutrition Society. Volume 73:Issue 1(2014)
• Page Start: 73
• Page End: 79
• Publication Date: 2013-12-05
• Subjects: PUFA, -- n-3 Fatty acids, -- CVD, -- Inflammatory disease; Nutrition -- Congresses; 612.30993
• DOI: 10.1017/S0029665113003789
• Languages: English
• ISSNs: 0029-6651

Abstract

Abstract : This review considers evidence for a protective effect of PUFA on chronic disease. Estimates of PUFA intakes in prospective cohort studies are usually based on FFQ or biomarkers of intake. Cohort studies suggest that both linoleic and linolenic acid intake are associated with a lower risk of CHD. The intake of fish, the major source of long-chain n- 3 PUFA is associated with a lower risk of both stroke and CHD, particularly sudden cardiac death. No relationship with common sites of cancer (breast and colon) and PUFA has been found. However, some recent studies suggest an association of high intakes of n -3 PUFA with risk of prostate cancer. An updated Cochrane review of dietary fat modification (replacing SFA with PUFA) randomised controlled trials to prevent CHD found a 14 % lower incidence and a non-significant 7 % lower mortality from CHD. The effects of an increased intake of n -3 PUFA on CHD incidence mortality have been tested in patients with pre-existing CHD in randomised controlled trials. Meta-analysis of these trials showed no overall benefit on total mortality or CVD incidence but a trend for lower risk of cardiac death was 0·91 (95 % CI 0·85, 0·98). At present, there is little evidence from other trials demonstrating the clear benefits or harm from increased intakes of PUFA. In conclusion, present evidence intakes benefit from partial replacement of SFA with a balanced mixture of n -6 and n -3 PUFA which may contribute to CVD prevention.